• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-31a-5p 的去调控通过靶向 TP53 抑制肺动脉平滑肌细胞凋亡参与原发性高血压的发生。

Deregulation of microRNA‑31a‑5p is involved in the development of primary hypertension by suppressing apoptosis of pulmonary artery smooth muscle cells via targeting TP53.

机构信息

Department of Laboratory, The People's Hospital of Tongchuan, Tongchuan, Shaanxi 727000, P.R. China.

Department of Laboratory, Second Affiliated Hospital of Shaanxi Chinese Traditional Medicine, Xianyang, Shaanxi 712000, P.R. China.

出版信息

Int J Mol Med. 2018 Jul;42(1):290-298. doi: 10.3892/ijmm.2018.3597. Epub 2018 Mar 29.

DOI:10.3892/ijmm.2018.3597
PMID:29620173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5979825/
Abstract

The present study aimed to identify the association between microRNA (miRNA/miR)‑31a‑5p and the development of hypertension, and its potential molecular mechanism. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blot analyses were performed to validate the candidate miRNA and genes involved in hypertension, following which an online miRNA database search, luciferase assay, and RT‑qPCR and western blot analyses were performed to confirm the interaction between miR‑31a‑5p and TP53. A MTT assay and flow cytometric analysis were utilized to determine the effect of miR‑31a‑5p on cell growth and apoptosis. The results revealed that miR‑31a‑5p and TP53 were the candidate miRNA and gene regulating hypertension, and that TP53 was the virtual target gene of miR‑31a‑5p with a binding site located in the TP53 3' untranslated region (3'UTR). It was confirmed by luciferase activity that miR‑31a‑5p markedly reduced the luciferase activity of the Luc‑wild‑type‑TP53‑3'UTR, whereas the mutated putative miR‑31a‑5p binding located on the TP53‑3'UTR was found to eliminate such an inhibitory effect. miR‑31a‑5p had no effect on specificity protein 1, E2F transcription factor 2 or forkhead box P3 luciferase activity. Smooth muscle cells collected from spontaneously hypertensive rats treated with gold nano‑particles containing anti‑rno‑miR‑31a‑5p exhibited a lower growth rate and a higher apoptotic rate. The results of the RT‑qPCR and western blot analyses showed that miR‑31a‑5p negatively regulated the expression of TP53, and transfection with the hsa‑miR‑31a‑5p mimic significantly promoted cell growth and inhibited cell apoptosis, whereas transfection with the anti‑hsa‑miR‑31a‑5p mimic significantly suppressed cell growth and induced cell apoptosis. Taken together, these findings indicated that miR‑31a‑5p is involved in hypertension via the accelerated proliferation of arterial smooth muscle cells and inhibition of apoptosis through targeting TP53.

摘要

本研究旨在探讨 microRNA(miRNA/miR)-31a-5p 与高血压发展之间的关联及其潜在的分子机制。通过逆转录-定量聚合酶链反应(RT-qPCR)和 Western blot 分析验证候选 miRNA 和与高血压相关的基因,然后通过在线 miRNA 数据库搜索、荧光素酶测定以及 RT-qPCR 和 Western blot 分析证实 miR-31a-5p 与 TP53 之间的相互作用。通过 MTT assay 和流式细胞术分析来确定 miR-31a-5p 对细胞生长和凋亡的影响。结果表明,miR-31a-5p 和 TP53 是调节高血压的候选 miRNA 和基因,而 TP53 是 miR-31a-5p 的虚拟靶基因,其结合位点位于 TP53 3'UTR。荧光素酶活性证实,miR-31a-5p 显著降低了 Luc-野生型-TP53-3'UTR 的荧光素酶活性,而位于 TP53-3'UTR 上的突变假定的 miR-31a-5p 结合位点则消除了这种抑制作用。miR-31a-5p 对特异性蛋白 1、E2F 转录因子 2 或 forkhead box P3 荧光素酶活性没有影响。用含抗 rno-miR-31a-5p 的金纳米颗粒处理的自发性高血压大鼠的平滑肌细胞表现出较低的生长速度和较高的凋亡率。RT-qPCR 和 Western blot 分析结果表明,miR-31a-5p 负调控 TP53 的表达,转染 hsa-miR-31a-5p 模拟物显著促进细胞生长并抑制细胞凋亡,而转染抗 hsa-miR-31a-5p 模拟物则显著抑制细胞生长并诱导细胞凋亡。综上所述,这些发现表明,miR-31a-5p 通过靶向 TP53 加速动脉平滑肌细胞增殖并抑制细胞凋亡参与高血压的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/818a8c4e8e74/IJMM-42-01-0290-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/4328223f4fdb/IJMM-42-01-0290-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/ed1de6a4cd8d/IJMM-42-01-0290-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/b2405a53d970/IJMM-42-01-0290-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/ccb407674b8d/IJMM-42-01-0290-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/6e198cf0cc9d/IJMM-42-01-0290-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/818a8c4e8e74/IJMM-42-01-0290-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/4328223f4fdb/IJMM-42-01-0290-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/ed1de6a4cd8d/IJMM-42-01-0290-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/b2405a53d970/IJMM-42-01-0290-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/ccb407674b8d/IJMM-42-01-0290-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/6e198cf0cc9d/IJMM-42-01-0290-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223c/5979825/818a8c4e8e74/IJMM-42-01-0290-g05.jpg

相似文献

1
Deregulation of microRNA‑31a‑5p is involved in the development of primary hypertension by suppressing apoptosis of pulmonary artery smooth muscle cells via targeting TP53.miR-31a-5p 的去调控通过靶向 TP53 抑制肺动脉平滑肌细胞凋亡参与原发性高血压的发生。
Int J Mol Med. 2018 Jul;42(1):290-298. doi: 10.3892/ijmm.2018.3597. Epub 2018 Mar 29.
2
MiR-31a-5p protects myocardial cells against apoptosis by targeting Tp53.miR-31a-5p 通过靶向 Tp53 保护心肌细胞免于凋亡。
Mol Med Rep. 2018 Mar;17(3):3898-3904. doi: 10.3892/mmr.2017.8357. Epub 2017 Dec 27.
3
rs78378222 polymorphism in the 3'-untranslated region of TP53 contributes to development of age-associated cataracts by modifying microRNA-125b-induced apoptosis of lens epithelial cells.TP53基因3'非翻译区的rs78378222多态性通过改变微小RNA-125b诱导的晶状体上皮细胞凋亡,促进年龄相关性白内障的发生发展。
Mol Med Rep. 2016 Sep;14(3):2305-10. doi: 10.3892/mmr.2016.5465. Epub 2016 Jul 4.
4
Downregulation of microRNA‑34b is responsible for the elevation of blood pressure in spontaneously hypertensive rats.微小RNA-34b的下调是自发性高血压大鼠血压升高的原因。
Mol Med Rep. 2017 Mar;15(3):1031-1036. doi: 10.3892/mmr.2017.6122. Epub 2017 Jan 16.
5
Upregulated miR-17 Regulates Hypoxia-Mediated Human Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis by Targeting Mitofusin 2.上调的miR-17通过靶向线粒体融合蛋白2调控缺氧介导的人肺动脉平滑肌细胞增殖和凋亡。
Med Sci Monit. 2016 Sep 18;22:3301-8. doi: 10.12659/msm.900487.
6
Long non-coding RNA and microRNA-675/let-7a mediates the protective effect of melatonin against early brain injury after subarachnoid hemorrhage via targeting TP53 and neural growth factor.长链非编码 RNA 和 microRNA-675/let-7a 通过靶向 TP53 和神经生长因子介导褪黑素对蛛网膜下腔出血后早期脑损伤的保护作用。
Cell Death Dis. 2018 Jan 24;9(2):99. doi: 10.1038/s41419-017-0155-8.
7
MiR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expression.微小RNA-140-5p通过靶向DNA甲基转移酶1(Dnmt1)并促进超氧化物歧化酶2(SOD2)的表达来调节缺氧介导的人肺动脉平滑肌细胞的增殖、凋亡和分化。
Biochem Biophys Res Commun. 2016 Apr 22;473(1):342-348. doi: 10.1016/j.bbrc.2016.03.116. Epub 2016 Mar 26.
8
Dysregulation of microRNA-214 and PTEN contributes to the pathogenesis of hypoxic pulmonary hypertension.微小RNA-214和PTEN的失调促成了缺氧性肺动脉高压的发病机制。
Int J Chron Obstruct Pulmon Dis. 2017 Jun 19;12:1781-1791. doi: 10.2147/COPD.S104627. eCollection 2017.
9
Pri-microRNA-124 rs531564 polymorphism minor allele increases the risk of pulmonary artery hypertension by abnormally enhancing proliferation of pulmonary artery smooth muscle cells.原发性微小RNA-124 rs531564多态性的次要等位基因通过异常增强肺动脉平滑肌细胞的增殖增加肺动脉高压的风险。
Int J Chron Obstruct Pulmon Dis. 2017 May 4;12:1351-1361. doi: 10.2147/COPD.S99318. eCollection 2017.
10
The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-α1C.microRNA-328 通过靶向胰岛素样生长因子 1 受体和 L 型钙通道-α1C 调节低氧性肺动脉高压。
Hypertension. 2012 May;59(5):1006-13. doi: 10.1161/HYPERTENSIONAHA.111.185413. Epub 2012 Mar 5.

引用本文的文献

1
Mining of potentially stem cell-related miRNAs in planarians.类星体中与干细胞相关的 miRNA 的挖掘。
Mol Biol Rep. 2024 Oct 8;51(1):1045. doi: 10.1007/s11033-024-09977-6.
2
Mining Important Herb Combinations of Traditional Chinese Medicine against Hypertension Based on the Symptom-Herb Network Combined with Network Pharmacology.基于症状-药物网络结合网络药理学挖掘抗高血压中药重要药对
Evid Based Complement Alternat Med. 2022 Mar 22;2022:5850899. doi: 10.1155/2022/5850899. eCollection 2022.
3
Serum miR-195-5p Exhibits Clinical Significance in the Diagnosis of Essential Hypertension with Type 2 Diabetes Mellitus by Targeting DRD1.

本文引用的文献

1
Association of Telomere Length With Chromosomal Damage Among Chinese Workers Exposed to Vinyl Chloride Monomer.端粒长度与氯乙烯单体接触中国工人染色体损伤的关联。
J Occup Environ Med. 2017 Dec;59(12):e252-e256. doi: 10.1097/JOM.0000000000001177.
2
Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy.通过 MEL18 抑制 HSF2 的 SUMOylation,上调 IGF-IIR,导致高血压诱导的心脏肥大。
Int J Cardiol. 2018 Apr 15;257:283-290. doi: 10.1016/j.ijcard.2017.10.102. Epub 2017 Nov 10.
3
MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension.
血清 miR-195-5p 通过靶向 DRD1 在诊断伴 2 型糖尿病的原发性高血压中的具有临床意义。
Clinics (Sao Paulo). 2021 Sep 3;76:e2502. doi: 10.6061/clinics/2021/e2502. eCollection 2021.
4
Cell landscape atlas for patients with chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy constructed using single-cell RNA sequencing.基于单细胞 RNA 测序的慢性血栓栓塞性肺动脉高压患者肺血管内皮细胞图谱构建。
Aging (Albany NY). 2021 Jun 21;13(12):16485-16499. doi: 10.18632/aging.203168.
5
Diurnal Timing Dependent Alterations in Gut Microbial Composition Are Synchronously Linked to Salt-Sensitive Hypertension and Renal Damage.昼夜节律相关的肠道微生物组成改变与盐敏感性高血压和肾脏损伤同步相关。
Hypertension. 2020 Jul;76(1):59-72. doi: 10.1161/HYPERTENSIONAHA.120.14830. Epub 2020 May 26.
6
miR‑106b‑5p modulates acute pulmonary embolism via NOR1 in pulmonary artery smooth muscle cells.miR-106b-5p 通过肺动脉平滑肌细胞中的 NOR1 调节急性肺栓塞。
Int J Mol Med. 2020 May;45(5):1525-1533. doi: 10.3892/ijmm.2020.4532. Epub 2020 Mar 9.
7
Noncoding RNAs in Hypertension.高血压中的非编码RNA
Hypertension. 2019 Sep;74(3):477-492. doi: 10.1161/HYPERTENSIONAHA.119.13412. Epub 2019 Jul 29.
8
A New Insight into the Roles of MiRNAs in Metabolic Syndrome.miRNAs 在代谢综合征中的作用的新见解。
Biomed Res Int. 2018 Dec 17;2018:7372636. doi: 10.1155/2018/7372636. eCollection 2018.
在肺动脉高压的Sugen5416/低氧/常氧模型的右心室中,微小RNA-140水平升高,而线粒体融合蛋白-1表达下调。
Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H689-98. doi: 10.1152/ajpheart.00264.2016. Epub 2016 Jul 15.
4
A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.一种多效性RNA结合蛋白控制不同的细胞周期检查点,以驱动p53缺陷型肿瘤对化疗的抗性。
Cancer Cell. 2015 Nov 9;28(5):623-637. doi: 10.1016/j.ccell.2015.09.009.
5
Hypertrophic and antihypertrophic microRNA levels in peripheral blood mononuclear cells and their relationship to left ventricular hypertrophy in patients with essential hypertension.原发性高血压患者外周血单个核细胞中肥厚性和抗肥厚性微小RNA水平及其与左心室肥厚的关系。
J Am Soc Hypertens. 2015 Oct;9(10):802-810. doi: 10.1016/j.jash.2015.07.013. Epub 2015 Aug 1.
6
Gene Expression and MicroRNA Expression Analysis in Small Arteries of Spontaneously Hypertensive Rats. Evidence for ER Stress.自发性高血压大鼠小动脉中的基因表达和微小RNA表达分析。内质网应激的证据。
PLoS One. 2015 Sep 10;10(9):e0137027. doi: 10.1371/journal.pone.0137027. eCollection 2015.
7
Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats.p53失活足以诱导大鼠肺动脉高压的发生。
PLoS One. 2015 Jun 29;10(6):e0131940. doi: 10.1371/journal.pone.0131940. eCollection 2015.
8
MiR-31 Downregulation Protects Against Cardiac Ischemia/Reperfusion Injury by Targeting Protein Kinase C Epsilon (PKCε) Directly.微小RNA-31的下调通过直接靶向蛋白激酶Cε(PKCε)来预防心脏缺血/再灌注损伤。
Cell Physiol Biochem. 2015;36(1):179-90. doi: 10.1159/000374062. Epub 2015 Apr 30.
9
Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.携带抗EBV-miR-BART7-3p的金纳米颗粒(AuNPs)可抑制EBV阳性鼻咽癌的生长。
Oncotarget. 2015 Apr 10;6(10):7838-50. doi: 10.18632/oncotarget.3046.
10
Tumor suppression by miR-31 in esophageal carcinoma is p21-dependent.miR-31在食管癌中的肿瘤抑制作用依赖于p21。
Genes Cancer. 2014 Nov;5(11-12):436-44. doi: 10.18632/genesandcancer.38.